Literature DB >> 25314076

Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities.

Ryan J Davis1, Markus Welcker2, Bruce E Clurman3.   

Abstract

Tumor suppressors with widespread impact on carcinogenesis control broad spectra of oncogenic pathways. Protein degradation is an emerging mechanism by which tumor suppressors regulate a diversity of pathways and is exemplified by the SCF(Fbw7) ubiquitin ligase. Rapidly accumulating data indicate that SCF(Fbw7) regulates a network of crucial oncoproteins. Importantly, the FBXW7 gene, which encodes Fbw7, is one of the most frequently mutated genes in human cancers. These studies are yielding important new insights into tumorigenesis and may soon enable therapies targeting the Fbw7 pathway. Here, we focus on the mechanisms and consequences of Fbw7 deregulation in cancers and discuss possible therapeutic approaches.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25314076      PMCID: PMC4227608          DOI: 10.1016/j.ccell.2014.09.013

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  102 in total

1.  Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor.

Authors:  N Gupta-Rossi; O Le Bail; H Gonen; C Brou; F Logeat; E Six; A Ciechanover; A Israël
Journal:  J Biol Chem       Date:  2001-06-25       Impact factor: 5.157

2.  Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.

Authors:  Masayoshi Yada; Shigetsugu Hatakeyama; Takumi Kamura; Masaaki Nishiyama; Ryosuke Tsunematsu; Hiroyuki Imaki; Noriko Ishida; Fumihiko Okumura; Keiko Nakayama; Keiichi I Nakayama
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

3.  Chromosome instability underlies hematopoietic stem cell dysfunction and lymphoid neoplasia associated with impaired Fbw7-mediated cyclin E regulation.

Authors:  Ka Tat Siu; Yanfei Xu; Kelsey L Swartz; Mitra Bhattacharyya; Sandeep Gurbuxani; Youjia Hua; Alex C Minella
Journal:  Mol Cell Biol       Date:  2014-06-23       Impact factor: 4.272

4.  Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver.

Authors:  Ichiro Onoyama; Atsushi Suzuki; Akinobu Matsumoto; Kengo Tomita; Hideki Katagiri; Yuichi Oike; Keiko Nakayama; Keiichi I Nakayama
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

5.  The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog.

Authors:  C Oberg; J Li; A Pauley; E Wolf; M Gurney; U Lendahl
Journal:  J Biol Chem       Date:  2001-07-18       Impact factor: 5.157

Review 6.  The ubiquitous nature of cancer: the role of the SCF(Fbw7) complex in development and transformation.

Authors:  K M Crusio; B King; L B Reavie; I Aifantis
Journal:  Oncogene       Date:  2010-06-14       Impact factor: 9.867

7.  A colon cancer-derived mutant of Krüppel-like factor 5 (KLF5) is resistant to degradation by glycogen synthase kinase 3β (GSK3β) and the E3 ubiquitin ligase F-box and WD repeat domain-containing 7α (FBW7α).

Authors:  Agnieszka B Bialkowska; Yang Liu; Mandayam O Nandan; Vincent W Yang
Journal:  J Biol Chem       Date:  2014-01-07       Impact factor: 5.157

Review 8.  Recognition and processing of ubiquitin-protein conjugates by the proteasome.

Authors:  Daniel Finley
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover.

Authors:  Christy J Fryer; J Brandon White; Katherine A Jones
Journal:  Mol Cell       Date:  2004-11-19       Impact factor: 17.970

10.  CDC4/FBXW7 and the 'just enough' model of tumourigenesis.

Authors:  Hayley Davis; Ian Tomlinson
Journal:  J Pathol       Date:  2012-04-18       Impact factor: 7.996

View more
  169 in total

1.  Fbxw7 suppresses cancer metastasis by inhibiting niche formation.

Authors:  Kanae Yumimoto; Keiichi I Nakayama
Journal:  Oncoimmunology       Date:  2015-06-03       Impact factor: 8.110

Review 2.  Dysregulation of ubiquitin ligases in cancer.

Authors:  Jianfei Qi; Ze'ev A Ronai
Journal:  Drug Resist Updat       Date:  2015-09-28       Impact factor: 18.500

Review 3.  Ubiquitin, the centrosome, and chromosome segregation.

Authors:  Ying Zhang; Paul J Galardy
Journal:  Chromosome Res       Date:  2016-01       Impact factor: 5.239

4.  FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells.

Authors:  Rizwan Saffie; Nan Zhou; Delphine Rolland; Özlem Önder; Venkatesha Basrur; Sydney Campbell; Kathryn E Wellen; Kojo S J Elenitoba-Johnson; Brian C Capell; Luca Busino
Journal:  Cancer Res       Date:  2020-04-29       Impact factor: 12.701

5.  Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism.

Authors:  Ryan J Davis; Mehmet Gönen; Daciana H Margineantu; Shlomo Handeli; Jherek Swanger; Pia Hoellerbauer; Patrick J Paddison; Haiwei Gu; Daniel Raftery; Jonathan E Grim; David M Hockenbery; Adam A Margolin; Bruce E Clurman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

6.  Copy Number Aberrations of Multiple Genes Identified as Prognostic Markers for Extrahepatic Metastasis-free Survival of Patients with Hepatocellular Carcinoma.

Authors:  Zhong-Zheng Zhu; Ling-Ling Bao; Kun Zhao; Qing Xu; Jia-Yi Zhu; Ke-Xuan Zhu; Bing-Ji Wen; Ying-Quan Ye; Xiao-Xi Wan; Liang-Liang Wang; Song-Qin He; Wen-Ming Cong
Journal:  Curr Med Sci       Date:  2019-10-14

7.  Identification of aberrantly expressed F-box proteins in squamous-cell lung carcinoma.

Authors:  Kai Wang; Xiao Qu; Shaorui Liu; Xudong Yang; Fenglong Bie; Yu Wang; Cuicui Huang; Jiajun Du
Journal:  J Cancer Res Clin Oncol       Date:  2018-05-04       Impact factor: 4.553

8.  E3 ligase FBXW7 aggravates TMPD-induced systemic lupus erythematosus by promoting cell apoptosis.

Authors:  Zhenlu Chong; Chunjing Bao; Jia He; Tianxiao Chen; Lijia Zhong; Gaopeng Li; Huanle Li; Lutong Fang; Yinjing Song; Guoxiang Fu; Xuyan Yang; Lihua Lai; Yang Liu; Qingqing Wang
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

Review 9.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

Review 10.  A structural view of PA2G4 isoforms with opposing functions in cancer.

Authors:  Brendan W Stevenson; Michael A Gorman; Jessica Koach; Belamy B Cheung; Glenn M Marshall; Michael W Parker; Jessica K Holien
Journal:  J Biol Chem       Date:  2020-09-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.